𝗛𝗲𝗮𝗹𝘁𝗵 𝗠𝗶𝗻𝗶𝘀𝘁𝗲𝗿 𝗮𝗽𝗽𝗹𝗮𝘂𝗱𝘀 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽 𝘁𝗼 𝗲𝘀𝘁𝗮𝗯𝗹𝗶𝘀𝗵 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝘆 𝗶𝗻 𝗔𝗸𝘂𝘀𝗲

The Ministry of Health has officially welcomed a groundbreaking partnership between South Korea’s GL RAPHA and Ghana’s Quintex Pharma, aimed at establishing a cutting-edge biopharmaceutical manufacturing facility in Akuse.

The planned facility is expected to produce critical care injectable medicines locally, significantly reducing Ghana’s dependency on pharmaceutical imports. It will also create over 560 skilled direct jobs, foster local pharmaceutical expertise through advanced training programs, and serve as a centre for technology transfer within the sub-region.

At a high-level investor engagement, the Minister for Health, Kwabena Mintah Akandoh, acknowledged the project’s strategic alignment with Ghana’s national development priorities.

He noted its relevance to strengthening pharmaceutical self-sufficiency, supporting the Government’s 24-Hour Economy policy, and advancing industrialisation within the health sector.

The initiative is set to enhance Ghana’s capacity to respond swiftly to health emergencies and improve pharmaceutical exports under the African Continental Free Trade Area (AfCFTA) and ECOWAS trade frameworks.

The GL RAPHA–Quintex Pharma collaboration represents a major step in Ghana-South Korea relations, leveraging innovation and industrial capacity to drive sustainable healthcare development.

The Ministry of Health has assured its full support to ensure the success and long-term impact of the project on both national and regional healthcare delivery.